Prosecution Insights
Last updated: April 19, 2026

Gi Cell Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
0
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18559381 COMPOSITION FOR NK CELL CRYOPRESERVATION AND CRYOPRESERVATION FORMULATION COMPRISING SAME AMICK, THOMAS RUSSE 1638 Non-Final OA Nov 07, 2023
18044365 CORONAVIRUS-DERIVED RECEPTOR-BINDING DOMAIN VARIANT HAVING REDUCED ACE2-BINDING AFFINITY AND VACCINE COMPOSITION COMPRISING THE SAME REDDIG, PETER J 1646 Non-Final OA Mar 07, 2023
18044245 FUSION PROTEIN COMPRISING CORONAVIRUS-DERIVED RECEPTOR-BINDING DOMAIN AND NUCLEOCAPSID PROTEIN, AND USE THEREOF CHEN, STACY BROWN 1672 Non-Final OA Mar 07, 2023

Managing Gi Cell Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month